Showing results (641-650 of 2,481) with videos related to

Sort By:
Pageof 249
Pediatric Hematology and Oncology|January 1, 1989
School-related behavior in children with cancerA F Mancini, P Rosito, R Canino, et al.
Pediatric Hematology and Oncology|January 1, 1989
Malignant histiocytosis involving pancreas at initial presentationT Hara, H Igarashi, Y Mizuno, et al.
Pediatric Hematology and Oncology|July 25, 2022
Whole genome sequencing and inheritance-based variant filtering as a tool for unraveling missing heritability in pediatric cancerCharlotte Derpoorter, Ruben Van Paemel, Katrien Vandemeulebroecke, et al.
Pediatric Hematology and Oncology|May 3, 2022
Tyrosine kinase inhibitor treatment and long-term follow-up for metastatic malignant struma ovariiTarek Taha, Hosam Abu-Sini, Salem Billan
Pediatric Hematology and Oncology|July 14, 2022
Estimation of iron overload with T2*MRI in children treated for hematological malignanciesVinay Munikoty, Kushaljit Singh Sodhi, Anmol Bhatia, et al.
Pediatric Hematology and Oncology|July 15, 2022
Internal evaluation of risk stratification tool using serial procalcitonin and clinical risk factors in pediatric febrile neutropenia: The non-interventional, single institution experience prior to clinical implementationC N Nessle, T Braun, S W Choi, et al.
Pediatric Hematology and Oncology|January 1, 1988
Nutrition, infection, and morbidity in leukemiaM S Kibirige, P H Morris-Jones, R F Stevens, et al.
Pediatric Hematology and Oncology|January 1, 1986
Immunological abnormalities in a child with constitutional aplastic anemiaM Dohlsten, R Carlsson, G Hedlund, et al.
Pediatric Hematology and Oncology|September 17, 2019
A homozygote novel L451W mutation in CECR1 gene causes deficiency of adenosine deaminase 2 in a pediatric patient representing with chronic lymphoproliferation and cytopeniaRabia Miray Kisla Ekinci, Sibel Balcı, Atil Bisgin, et al.
Pediatric Hematology and Oncology|September 17, 2019
"Feasible and effective administration of Bortezomib with Rituximab in children with relapsed/resistant B-cell precursor acute lymphoblastic leukemia (BCP-ALL): A step toward the first line"Luca Lo Nigro, Giulio Pulvirenti, Emanuela Cannata, et al.
Pageof 249